Evidence map›Paper›PMID 37195444›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2023

A machine learning method integrating ECG and gated SPECT for cardiac resynchronization therapy decision support.

Fernando de A Fernandes, Kristoffer Larsen, Zhuo He, Erivelton Nascimento, Amalia Peix, Qiuying Sha, Diana Paez, Ernest V Garcia, Weihua Zhou, Claudio T Mesquita

Abstract read
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. AI in SPECT Imaging: Opportunities and Challenges.Seminars in nuclear medicine · 2025
    Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Fernando de A Fernandes *Nuclear Medicine Department, Hospital Universitario Antonio Pedro-EBSERH-UFF, 303 Marquês de Parana Street, Niteroi, Rio de Janeiro, 24033-900, Brazil. fernando.fernandes2@gmail.com.ORCID 0000-0002-6030-9486
Kristoffer Larsen *Department of Mathematical Sciences, Michigan Technological University, Houghton, MI, USA.
Zhuo HeDepartment of Applied Computing, Michigan Technological University, 1400 Townsend Dr, Houghton, MI, 49931, USA.
Erivelton NascimentoCardiology Department, Hospital Universitario Antonio Pedro-EBSERH-UFF, Niteroi, Brazil.
Amalia PeixNuclear Medicine Department, Institute of Cardiology, La Habana, Cuba.
Qiuying ShaDepartment of Mathematical Sciences, Michigan Technological University, Houghton, MI, USA.
Diana PaezNuclear Medicine and Diagnostic Imaging Section, Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria.
Ernest V GarciaDepartment of Radiology and Imaging Sciences, Emory University, Atlanta, GA, USA.
Weihua ZhouDepartment of Applied Computing, Michigan Technological University, 1400 Townsend Dr, Houghton, MI, 49931, USA. whzhou@mtu.edu.
Claudio T MesquitaNuclear Medicine Department, Hospital Universitario Antonio Pedro-EBSERH-UFF, 303 Marquês de Parana Street, Niteroi, Rio de Janeiro, 24033-900, Brazil.
Michigan Technological University · USHospital Universitário Antônio Pedro · BREmory University · USInternational Atomic Energy Agency · AT

Funding

American Heart Association-American Stroke Association 17AIREA33700016
6 · The paper itself

Abstract

purposeCardiac resynchronization therapy (CRT) has been established as an important therapy for heart failure. Mechanical dyssynchrony has the potential to predict responders to CRT. The aim of this study was to report the development and the validation of machine learning models which integrate ECG, gated SPECT MPI (GMPS), and clinical variables to predict patients' response to CRT.

methodsThis analysis included 153 patients who met criteria for CRT from a prospective cohort study. The variables were used to model predictive methods for CRT. Patients were classified as "responders" for an increase of LVEF ≥ 5% at follow-up. In a second analysis, patients were classified as "super-responders" for an increase of LVEF ≥ 15%. For ML, variable selection was applied, and Prediction Analysis of Microarrays (PAM) approach was used to model response while Naïve Bayes (NB) was used to model super-response. These ML models were compared to models obtained with guideline variables.

resultsPAM had AUC of 0.80 against 0.72 of partial least squares-discriminant analysis with guideline variables (p = 0.52). The sensitivity (0.86) and specificity (0.75) were better than for guideline alone, sensitivity (0.75) and specificity (0.24). Neural network with guideline variables was better than NB (AUC = 0.93 vs. 0.87) however without statistical significance (p = 0.48). Its sensitivity and specificity (1.0 and 0.75, respectively) were better than guideline alone (0.78 and 0.25, respectively).

conclusionsCompared to guideline criteria, ML methods trended toward improved CRT response and super-response prediction. GMPS was central in the acquisition of most parameters. Further studies are needed to validate the models.

Indexed as

Cardiac Resynchronization TherapyHeart FailureBayes TheoremElectrocardiographyGuanosine MonophosphateHumansMachine LearningProspective StudiesThionucleotidesTomography, Emission-Computed, Single-PhotonTreatment Outcomeguanosine 5'-monophosphorothioateGuanosine MonophosphateThionucleotidesCRTHeart failureMachine learningSPECT

Identifiers

PMID37195444
PMCPMC10959568
OpenAlexW4376872154

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.